Skip to content

Unitedhealth Group

NYSE: UNH · USD

Unitedhealth Group cash flow and EPS50

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$5,630M
Unitedhealth Group capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q211.05% · $151M29.28% · $400M59.66% · $815MUnavailable0% · $0M100% · $1,366M
FY 2009 Q325% · $172M0.29% · $2M9.3% · $64M0% · $0M65.41% · $450M100% · $688M
FY 2009 Q444.68% · $256M14.66% · $84M40.66% · $233M0% · $0M0% · $0M100% · $573M
FY 2010 Q17.91% · $132M4.67% · $78M37.51% · $626M0% · $0M49.91% · $833M100% · $1,669M
FY 2010 Q213.3% · $211M5.48% · $87M38.75% · $615M10.96% · $174M31.51% · $500M100% · $1,587M
FY 2010 Q37.06% · $205M65.71% · $1,907M22.43% · $651M4.79% · $139M0% · $0M100% · $2,902M
FY 2010 Q420.73% · $330M15.77% · $251M39.26% · $625M8.54% · $136M15.7% · $250M100% · $1,592M
FY 2011 Q18.64% · $213M21.96% · $541M25.16% · $620M5.48% · $135M38.76% · $955M100% · $2,464M
FY 2011 Q221.67% · $303M20.46% · $286M45.42% · $635M12.45% · $174M0% · $0M100% · $1,398M
FY 2011 Q314.86% · $290M33.35% · $651M42.98% · $839M8.81% · $172M0% · $0M100% · $1,952M
FY 2011 Q415.38% · $261M21.57% · $366M53.03% · $900M10.02% · $170M0% · $0M100% · $1,697M
FY 2012 Q18% · $269M57.54% · $1,935M29.47% · $991M5% · $168M0% · $0M100% · $3,363M
FY 2012 Q211.52% · $196M27.57% · $469M48.09% · $818M12.82% · $218M0% · $0M100% · $1,701M
FY 2012 Q315.29% · $321M6.95% · $146M37.38% · $785M10.33% · $217M30.05% · $631M100% · $2,100M
FY 2012 Q45.59% · $284M73.48% · $3,730M9.65% · $490M4.28% · $217M6.99% · $355M100% · $5,076M
FY 2013 Q113.25% · $323M11.44% · $279M22.27% · $543M8.86% · $216M44.18% · $1,077M100% · $2,438M
FY 2013 Q216.22% · $302M0.27% · $5M42.48% · $791M15.09% · $281M25.94% · $483M100% · $1,862M
FY 2013 Q321.22% · $361M2.7% · $46M59.61% · $1,014M16.46% · $280M0% · $0M100% · $1,701M
FY 2013 Q421.36% · $321M2.13% · $32M54.69% · $822M18.56% · $279M3.26% · $49M100% · $1,503M
FY 2014 Q117.16% · $353M16.77% · $345M44.29% · $911M13.42% · $276M8.36% · $172M100% · $2,057M
FY 2014 Q218.78% · $363M9.21% · $178M53.08% · $1,026M18.93% · $366M0% · $0M100% · $1,933M
FY 2014 Q314.35% · $405M11.62% · $328M38.52% · $1,087M12.83% · $362M22.68% · $640M100% · $2,822M
FY 2014 Q414.34% · $404M38.04% · $1,072M34.92% · $984M12.7% · $358M0% · $0M100% · $2,818M
FY 2015 Q114.25% · $373M21.97% · $575M34.24% · $896M13.64% · $357M15.9% · $416M100% · $2,617M
FY 2015 Q216.5% · $343M57.86% · $1,203M2.74% · $57M22.9% · $476M0% · $0M100% · $2,079M
FY 2015 Q32.31% · $356M93.45% · $14,405M1.15% · $177M3.09% · $477M0% · $0M100% · $15,415M
FY 2015 Q429.24% · $484MUnavailable4.23% · $70M28.76% · $476M37.76% · $625M100% · $1,655M
FY 2016 Q111.49% · $425M45.86% · $1,697M13.51% · $500M12.89% · $477M16.24% · $601M100% · $3,700M
FY 2016 Q213.86% · $388M12.07% · $338M17.14% · $480M21.21% · $594M35.71% · $1,000M100% · $2,800M
FY 2016 Q317.46% · $407M29.69% · $692M5.88% · $137M25.53% · $595M21.45% · $500M100% · $2,331M
FY 2016 Q427.91% · $485MUnavailable9.38% · $163M34.23% · $595M28.48% · $495M100% · $1,738M
FY 2017 Q113.91% · $507M12.84% · $468M18.71% · $682M16.35% · $596M38.19% · $1,392M100% · $3,645M
FY 2017 Q216.95% · $418M9.57% · $236M14.72% · $363M29.36% · $724M29.4% · $725M100% · $2,466M
FY 2017 Q320.49% · $466M8.97% · $204M5.63% · $128M31.93% · $726M32.98% · $750M100% · $2,274M
FY 2017 Q414.23% · $632M27.55% · $1,223M7.36% · $327M16.37% · $727M34.48% · $1,531M100% · $4,440M
FY 2018 Q16.33% · $477M34.29% · $2,583M35.18% · $2,650M9.59% · $722M14.6% · $1,100M100% · $7,532M
FY 2018 Q225.39% · $483M2.79% · $53M26.29% · $500M45.53% · $866M0% · $0M100% · $1,902M
FY 2018 Q38.26% · $545M48.31% · $3,188M7.58% · $500M13.12% · $866M22.73% · $1,500M100% · $6,599M
FY 2018 Q422.8% · $558M7.07% · $173M34.74% · $850M35.39% · $866M0% · $0M100% · $2,447M
FY 2019 Q18.83% · $562M10.83% · $689M47.18% · $3,002M13.52% · $860M19.64% · $1,250M100% · $6,363M
FY 2019 Q25.93% · $415M58.03% · $4,062M21.41% · $1,499M14.63% · $1,024M0% · $0M100% · $7,000M
FY 2019 Q38.05% · $444M62.52% · $3,449M10.88% · $600M18.56% · $1,024M0% · $0M100% · $5,517M
FY 2019 Q423.93% · $650M5.27% · $143M14.69% · $399M37.7% · $1,024M18.41% · $500M100% · $2,716M
FY 2020 Q111.4% · $469M22.59% · $929M41.11% · $1,691M24.9% · $1,024M0% · $0M100% · $4,113M
FY 2020 Q29.67% · $451M64.84% · $3,023M0% · $0M25.48% · $1,188M0% · $0M100% · $4,662M
FY 2020 Q312.46% · $557M8.37% · $374M19.02% · $850M26.58% · $1,188M33.56% · $1,500M100% · $4,469M
FY 2020 Q47.24% · $574M35.47% · $2,813M21.55% · $1,709M14.93% · $1,184M20.81% · $1,650M100% · $7,930M
FY 2021 Q19.89% · $568M20.78% · $1,193M28.74% · $1,650M20.57% · $1,181M20.03% · $1,150M100% · $5,742M
FY 2021 Q27.62% · $562M46.75% · $3,449M16.94% · $1,250M18.53% · $1,367M10.17% · $750M100% · $7,378M
FY 2021 Q320.09% · $629M2.71% · $85M33.54% · $1,050M43.66% · $1,367M0% · $0M100% · $3,131M
FY 2021 Q415.6% · $695M2.11% · $94M23.57% · $1,050M30.65% · $1,365M28.06% · $1,250M100% · $4,454M
FY 2022 Q18.22% · $555M18.24% · $1,231M37.04% · $2,500M20.2% · $1,363M16.3% · $1,100M100% · $6,749M
FY 2022 Q26.19% · $657M55.73% · $5,919M23.54% · $2,500M14.55% · $1,545M0% · $0M100% · $10,621M
FY 2022 Q316.96% · $724M0.09% · $4M23.42% · $1,000M36.11% · $1,542M23.42% · $1,000M100% · $4,270M
FY 2022 Q44.65% · $866M76.8% · $14,304M5.37% · $1,000M8.27% · $1,541M4.91% · $915M100% · $18,626M
FY 2023 Q15.63% · $760M57.98% · $7,826M14.82% · $2,000M11.39% · $1,537M10.19% · $1,375M100% · $13,498M
FY 2023 Q212.45% · $829M5.03% · $335M45.04% · $3,000M26.23% · $1,747M11.26% · $750M100% · $6,661M
FY 2023 Q319.47% · $838M5.3% · $228M34.84% · $1,500M40.39% · $1,739M0% · $0M100% · $4,305M
FY 2023 Q416.13% · $959M29.39% · $1,747M25.24% · $1,500M29.24% · $1,738M0% · $0M100% · $5,944M
FY 2024 Q17.99% · $743M32.32% · $3,006M33.03% · $3,072M18.59% · $1,729M8.06% · $750M100% · $9,300M
FY 2024 Q222.37% · $853M0.66% · $25M0% · $0M50.75% · $1,935M26.23% · $1,000M100% · $3,813M
FY 2024 Q37.46% · $991M65.1% · $8,643M7.2% · $956M14.59% · $1,937M5.65% · $750M100% · $13,277M
FY 2024 Q49.07% · $912M17.25% · $1,734M49.47% · $4,972M19.22% · $1,932M4.98% · $500M100% · $10,050M
FY 2025 Q113.79% · $898M10.78% · $702M46.07% · $3,000M29.36% · $1,912M0% · $0M100% · $6,512M
FY 2025 Q216.22% · $886M0.59% · $32M46.59% · $2,545M36.61% · $2,000M0% · $0M100% · $5,463M
FY 2025 Q310.36% · $890M43.08% · $3,702M0% · $0M23.3% · $2,002M23.27% · $2,000M100% · $8,594M
FY 2025 Q423.28% · $948M1.79% · $73M0% · $0M49.15% · $2,002M25.78% · $1,050M100% · $4,073M
FY 2026 Q117.88% · $763M0% · $0M0% · $0M46.98% · $2,005M35.15% · $1,500M100% · $4,268M
FY 2026 Q214.19% · $799M1.74% · $98M29.24% · $1,646M37.07% · $2,087M17.76% · $1,000M100% · $5,630M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$11,052M

Capital expenditures

USD millions

$799M

Free cash flow

USD millions

$10,253M

Stock-based compensation

USD millions

$276M

SBC / free cash flow

% · FCF before SBC deduction

2.69%

SBC / operating cash flow

%

2.5%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$6.04

Quarterly data

Unitedhealth Group cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 202611,05279910,2532762.69%2.5%—$6.04
FY 2026 Q1Mar 31, 20268,9127638,1493484.27%3.9%—$6.9
FY 2025 Q4Dec 31, 20251,108948160176110%15.88%——
FY 2025 Q3Sep 30, 20255,9458905,0552234.41%3.75%—$2.59
FY 2025 Q2Jun 30, 20257,1888866,3021973.13%2.74%—$3.74
FY 2025 Q1Mar 31, 20255,4568984,5583758.23%6.87%—$6.85
FY 2024 Q4Dec 31, 20242,3699121,45718712.83%7.89%——
FY 2024 Q3Sep 30, 202413,94599112,9542371.83%1.7%—$6.51
FY 2024 Q2Jun 30, 20246,7468535,8932223.77%3.29%—$4.54
FY 2024 Q1Mar 31, 20241,14474340137292.77%32.52%—$-1.53
FY 2023 Q4Dec 31, 2023-5,193959-6,152208————
FY 2023 Q3Sep 30, 20236,9028386,0642474.07%3.58%—$6.24
FY 2023 Q2Jun 30, 202311,03282910,2032422.37%2.19%—$5.82
FY 2023 Q1Mar 31, 202316,32776015,5673622.33%2.22%—$5.95
FY 2022 Q4Dec 31, 2022-4,533866-5,399250————
FY 2022 Q3Sep 30, 202218,54972417,8251710.96%0.92%—$5.55
FY 2022 Q2Jun 30, 20226,8716576,2142053.3%2.98%—$5.34
FY 2022 Q1Mar 31, 20225,3195554,7642996.28%5.62%—$5.27
FY 2021 Q4Dec 31, 20213,2186952,5232098.28%6.49%——
FY 2021 Q3Sep 30, 20217,5806296,9511652.37%2.18%—$4.28
FY 2021 Q2Jun 30, 20215,5405624,9781703.42%3.07%—$4.46
FY 2021 Q1Mar 31, 20216,0055685,4372564.71%4.26%—$5.08
FY 2020 Q4Dec 31, 20206,1015745,5271522.75%2.49%——
FY 2020 Q3Sep 30, 20203,1275572,5701395.41%4.45%—$3.3
FY 2020 Q2Jun 30, 202010,0034519,5521571.64%1.57%—$6.91
FY 2020 Q1Mar 31, 20202,9434692,4742319.34%7.85%—$3.52
FY 2019 Q4Dec 31, 20196,2056505,5551723.1%2.77%——
FY 2019 Q3Sep 30, 20193,1504442,7061274.69%4.03%—$3.67
FY 2019 Q2Jun 30, 20195,8744155,4591552.84%2.64%—$3.42
FY 2019 Q1Mar 31, 20193,2345622,6722439.09%7.51%—$3.56
FY 2018 Q4Dec 31, 20182,3965581,8381266.86%5.26%——
FY 2018 Q3Sep 30, 201894154539615438.89%16.37%—$3.24
FY 2018 Q2Jun 30, 20184,0074833,5241504.26%3.74%—$2.98
FY 2018 Q1Mar 31, 20188,3694777,8922082.64%2.49%—$2.87
FY 2017 Q4Dec 31, 2017-2,577632-3,209141————
FY 2017 Q3Sep 30, 20177,5464667,0801241.75%1.64%—$2.51
FY 2017 Q2Jun 30, 20172,1714181,7531367.76%6.26%—$2.32
FY 2017 Q1Mar 31, 20176,4565075,9491963.29%3.04%—$2.23
FY 2016 Q4Dec 31, 2016-1,409485-1,894116————
FY 2016 Q3Sep 30, 20167,2034076,7961071.57%1.49%—$2.03
FY 2016 Q2Jun 30, 20161,6833881,2951058.11%6.24%—$1.81
FY 2016 Q1Mar 31, 20162,3184251,8931578.29%6.77%—$1.67
FY 2015 Q4Dec 31, 20153,5114843,0271003.3%2.85%——
FY 2015 Q3Sep 30, 20152,7973562,441953.89%3.4%—$1.65
FY 2015 Q2Jun 30, 20151,1633438208610.49%7.39%—$1.64
FY 2015 Q1Mar 31, 20152,2693731,8961256.59%5.51%—$1.46
FY 2014 Q4Dec 31, 20142,4294042,025954.69%3.91%——
FY 2014 Q3Sep 30, 20143,2004052,795812.9%2.53%—$1.63
FY 2014 Q2Jun 30, 20141,0143636518312.75%8.19%—$1.42
FY 2014 Q1Mar 31, 20141,4083531,0551059.95%7.46%—$1.1
FY 2013 Q4Dec 31, 20131,0683217477610.17%7.12%—$1.41
FY 2013 Q3Sep 30, 20133,3963613,035792.6%2.33%—$1.53
FY 2013 Q2Jun 30, 20131,4743021,172776.57%5.22%—$1.4
FY 2013 Q1Mar 31, 20131,0533237309913.56%9.4%—$1.16
FY 2012 Q4Dec 31, 20121,6822841,398926.58%5.47%—$1.2
FY 2012 Q3Sep 30, 2012-298321-61987———$1.5
FY 2012 Q2Jun 30, 20122,1851961,9891025.13%4.67%—$1.27
FY 2012 Q1Mar 31, 20123,5862693,3171404.22%3.9%—$1.31
FY 2011 Q4Dec 31, 2011-415261-67685———$1.17
FY 2011 Q3Sep 30, 20114,9642904,674982.1%1.97%—$1.17
FY 2011 Q2Jun 30, 20111,1953038929510.65%7.95%—$1.16
FY 2011 Q1Mar 31, 20111,2242131,01112312.17%10.05%—$1.22
FY 2010 Q4Dec 31, 20101,4413301,111766.84%5.27%—$0.94
FY 2010 Q3Sep 30, 20102,9042052,699833.08%2.86%—$1.14
FY 2010 Q2Jun 30, 20107232115126713.09%9.27%—$0.99
FY 2010 Q1Mar 31, 20101,2051321,0731009.32%8.3%—$1.03
FY 2009 Q4Dec 31, 20091,2802561,024757.32%5.86%—$0.81
FY 2009 Q3Sep 30, 20092,7411722,569793.08%2.88%—$0.89
FY 2009 Q2Jun 30, 20094921513418524.93%17.28%—$0.73
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · UNH, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.